Fundamentals of Particle Size Analysis
Summary: Micronization, the process of reducing the size of active pharmaceutical ingredient (API) particles to micrometer scale, plays a critical role in various pharmaceutical applications and analyzing micronized particles is essential to ensure their quality and performance. In both the early stages of research and development and the later commercial phases, achieving reliable and accurate particle size analysis is crucial for the success of pharmaceutical products. While some drug innovators may consider purchasing costly equipment or developing in-house expertise, many are now turning to outsourcing analytical testing as a faster, more efficient way to achieve precise and repeatable results.
As a trusted contract development and manufacturing organizations (CDMO), Catalent has the experienced team and equipment dedicated to particle size analysis, offering a cost-effective and efficient solution for pharmaceutical companies seeking to enhance their analytical capabilities. This article delves into fundamentals of understanding particle size characterization and the analytical capabilities used to assess micronized particles.